Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tumor Suppressor Proteins | 23 | 2016 | 2810 | 1.990 |
Why?
|
Camptothecin | 3 | 2024 | 600 | 1.470 |
Why?
|
Phosphoproteins | 10 | 2016 | 2451 | 1.410 |
Why?
|
Carcinoma, Squamous Cell | 14 | 2018 | 4058 | 1.390 |
Why?
|
Transcription Factors | 29 | 2020 | 12168 | 1.350 |
Why?
|
Trans-Activators | 13 | 2014 | 2857 | 1.340 |
Why?
|
Tumor Suppressor Protein p53 | 12 | 2022 | 2954 | 1.270 |
Why?
|
BRCA2 Protein | 8 | 2020 | 802 | 1.250 |
Why?
|
Immunoconjugates | 4 | 2024 | 975 | 1.200 |
Why?
|
Breast Neoplasms | 36 | 2024 | 21206 | 1.190 |
Why?
|
BRCA1 Protein | 11 | 2024 | 1155 | 1.070 |
Why?
|
DNA-Binding Proteins | 19 | 2016 | 9615 | 0.960 |
Why?
|
Cisplatin | 7 | 2015 | 1660 | 0.900 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2024 | 70 | 0.900 |
Why?
|
Nuclear Proteins | 12 | 2011 | 5804 | 0.830 |
Why?
|
ras Proteins | 4 | 2020 | 1058 | 0.830 |
Why?
|
Head and Neck Neoplasms | 6 | 2021 | 2931 | 0.760 |
Why?
|
Genes, Neoplasm | 3 | 2017 | 371 | 0.660 |
Why?
|
High-Throughput Nucleotide Sequencing | 7 | 2020 | 3671 | 0.620 |
Why?
|
Cell Line, Tumor | 19 | 2024 | 17140 | 0.620 |
Why?
|
Drug Resistance, Neoplasm | 8 | 2023 | 5341 | 0.610 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2021 | 637 | 0.610 |
Why?
|
GTPase-Activating Proteins | 1 | 2021 | 467 | 0.600 |
Why?
|
Protein Kinases | 7 | 2008 | 1611 | 0.600 |
Why?
|
Reactive Oxygen Species | 3 | 2015 | 2149 | 0.590 |
Why?
|
Haploinsufficiency | 1 | 2020 | 334 | 0.590 |
Why?
|
Genes, Tumor Suppressor | 5 | 2006 | 1062 | 0.580 |
Why?
|
Ovarian Neoplasms | 4 | 2016 | 4916 | 0.570 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 8 | 2019 | 905 | 0.570 |
Why?
|
Membrane Proteins | 8 | 2016 | 7876 | 0.530 |
Why?
|
Gene Fusion | 2 | 2021 | 356 | 0.520 |
Why?
|
Genetic Testing | 5 | 2015 | 3591 | 0.500 |
Why?
|
Genes, p53 | 5 | 2011 | 714 | 0.490 |
Why?
|
Adult Stem Cells | 2 | 2014 | 221 | 0.480 |
Why?
|
DNA Mutational Analysis | 5 | 2020 | 4120 | 0.480 |
Why?
|
Mutation | 27 | 2023 | 30238 | 0.470 |
Why?
|
DNA Damage | 4 | 2020 | 2469 | 0.460 |
Why?
|
Gene Expression Regulation, Neoplastic | 17 | 2019 | 8647 | 0.450 |
Why?
|
Thioredoxins | 1 | 2015 | 202 | 0.440 |
Why?
|
Carboplatin | 2 | 2021 | 797 | 0.430 |
Why?
|
Apoptosis | 10 | 2019 | 9523 | 0.420 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 8 | 2024 | 11878 | 0.420 |
Why?
|
Neuregulin-1 | 1 | 2014 | 136 | 0.420 |
Why?
|
Epithelial Cells | 5 | 2014 | 3703 | 0.410 |
Why?
|
Cysteine Endopeptidases | 1 | 2015 | 542 | 0.400 |
Why?
|
Wilms Tumor | 3 | 2013 | 378 | 0.400 |
Why?
|
Lipid Metabolism | 2 | 2020 | 1904 | 0.400 |
Why?
|
Nitrophenols | 1 | 2012 | 169 | 0.400 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2013 | 212 | 0.390 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2016 | 724 | 0.380 |
Why?
|
Lactation | 1 | 2014 | 392 | 0.380 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2016 | 2909 | 0.370 |
Why?
|
F-Box Proteins | 1 | 2012 | 199 | 0.370 |
Why?
|
Histone Deacetylase 2 | 1 | 2011 | 72 | 0.370 |
Why?
|
TOR Serine-Threonine Kinases | 10 | 2019 | 2062 | 0.370 |
Why?
|
Phosphatidylinositol 3-Kinases | 7 | 2015 | 2885 | 0.370 |
Why?
|
Neoplasms | 10 | 2024 | 22371 | 0.360 |
Why?
|
Mice | 34 | 2022 | 82029 | 0.350 |
Why?
|
Histone Deacetylase 1 | 1 | 2011 | 133 | 0.350 |
Why?
|
Germ-Line Mutation | 7 | 2021 | 1885 | 0.350 |
Why?
|
Cell Survival | 4 | 2011 | 5777 | 0.350 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2012 | 1406 | 0.350 |
Why?
|
Antineoplastic Agents | 9 | 2017 | 13676 | 0.330 |
Why?
|
Protein Isoforms | 8 | 2016 | 1715 | 0.330 |
Why?
|
Cell Hypoxia | 2 | 2012 | 662 | 0.330 |
Why?
|
Immunoprecipitation | 1 | 2012 | 874 | 0.330 |
Why?
|
Actins | 1 | 2016 | 2064 | 0.320 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2010 | 627 | 0.320 |
Why?
|
Wound Healing | 2 | 2017 | 2809 | 0.320 |
Why?
|
Transcriptional Activation | 6 | 2016 | 1750 | 0.320 |
Why?
|
Proteins | 6 | 2012 | 6009 | 0.310 |
Why?
|
Immunoblotting | 1 | 2012 | 1647 | 0.310 |
Why?
|
Animals | 41 | 2022 | 169246 | 0.300 |
Why?
|
Humans | 101 | 2024 | 768166 | 0.300 |
Why?
|
Histone Deacetylases | 1 | 2012 | 717 | 0.300 |
Why?
|
Heterozygote | 5 | 2020 | 2798 | 0.300 |
Why?
|
Genetic Predisposition to Disease | 9 | 2020 | 18065 | 0.290 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4912 | 0.290 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2012 | 778 | 0.290 |
Why?
|
Biphenyl Compounds | 1 | 2012 | 1026 | 0.290 |
Why?
|
Mice, Nude | 5 | 2019 | 3623 | 0.290 |
Why?
|
MicroRNAs | 3 | 2016 | 3803 | 0.280 |
Why?
|
Keratinocytes | 3 | 2006 | 876 | 0.280 |
Why?
|
Autophagy | 1 | 2015 | 1349 | 0.280 |
Why?
|
Loss of Heterozygosity | 2 | 2022 | 663 | 0.280 |
Why?
|
Receptors, Notch | 1 | 2011 | 751 | 0.270 |
Why?
|
Antigens, Neoplasm | 3 | 2024 | 1997 | 0.270 |
Why?
|
Estrogen Receptor alpha | 3 | 2023 | 581 | 0.270 |
Why?
|
Cell Adhesion Molecules | 2 | 2024 | 1613 | 0.270 |
Why?
|
Tumor Cells, Cultured | 11 | 2019 | 6124 | 0.250 |
Why?
|
Energy Metabolism | 3 | 2020 | 2907 | 0.250 |
Why?
|
WT1 Proteins | 3 | 2002 | 183 | 0.250 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5446 | 0.240 |
Why?
|
Pulmonary Emphysema | 1 | 2010 | 689 | 0.240 |
Why?
|
Neoplasms, Experimental | 1 | 2010 | 1230 | 0.240 |
Why?
|
Oxidative Stress | 4 | 2015 | 3139 | 0.230 |
Why?
|
Female | 56 | 2024 | 397192 | 0.230 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2024 | 108 | 0.230 |
Why?
|
Phthalazines | 2 | 2024 | 397 | 0.230 |
Why?
|
Genes, BRCA1 | 6 | 2017 | 755 | 0.220 |
Why?
|
Receptors, Estrogen | 5 | 2019 | 2253 | 0.220 |
Why?
|
Transcription, Genetic | 8 | 2013 | 7608 | 0.210 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2012 | 1901 | 0.210 |
Why?
|
Sulfonamides | 1 | 2012 | 1982 | 0.210 |
Why?
|
Isocitrate Dehydrogenase | 3 | 2014 | 951 | 0.210 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2021 | 3611 | 0.200 |
Why?
|
Signal Transduction | 13 | 2018 | 23645 | 0.200 |
Why?
|
Cell Cycle Proteins | 2 | 2014 | 3445 | 0.200 |
Why?
|
Paracrine Communication | 2 | 2014 | 278 | 0.190 |
Why?
|
Neoplasm Proteins | 4 | 2017 | 3603 | 0.190 |
Why?
|
Carrier Proteins | 1 | 2015 | 4937 | 0.190 |
Why?
|
Skin Neoplasms | 3 | 2020 | 5863 | 0.190 |
Why?
|
Promoter Regions, Genetic | 7 | 2017 | 5797 | 0.180 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2014 | 2846 | 0.180 |
Why?
|
Mice, Knockout | 9 | 2021 | 14488 | 0.180 |
Why?
|
Indazoles | 1 | 2022 | 306 | 0.180 |
Why?
|
Repressor Proteins | 3 | 2006 | 2982 | 0.170 |
Why?
|
Cell Proliferation | 8 | 2019 | 10474 | 0.170 |
Why?
|
Xenopus Proteins | 1 | 2002 | 435 | 0.170 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2023 | 565 | 0.170 |
Why?
|
Circadian Rhythm | 1 | 2011 | 2593 | 0.170 |
Why?
|
Mammary Glands, Animal | 2 | 2014 | 273 | 0.170 |
Why?
|
Single-Cell Analysis | 3 | 2021 | 2540 | 0.160 |
Why?
|
HEK293 Cells | 3 | 2020 | 4283 | 0.160 |
Why?
|
DNA Copy Number Variations | 2 | 2020 | 2048 | 0.160 |
Why?
|
Ribosomal Protein S6 Kinases | 2 | 2017 | 203 | 0.160 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2020 | 257 | 0.150 |
Why?
|
RNA Interference | 5 | 2020 | 2832 | 0.150 |
Why?
|
Glycolysis | 2 | 2021 | 837 | 0.150 |
Why?
|
Antibodies | 2 | 2020 | 2421 | 0.150 |
Why?
|
Feedback, Physiological | 2 | 2011 | 482 | 0.150 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 259 | 0.150 |
Why?
|
Genes, BRCA2 | 3 | 2017 | 593 | 0.150 |
Why?
|
Gene Expression Regulation | 7 | 2017 | 11928 | 0.150 |
Why?
|
Evolution, Molecular | 2 | 2022 | 1896 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2017 | 205 | 0.140 |
Why?
|
Cholangiocarcinoma | 2 | 2014 | 561 | 0.140 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2020 | 596 | 0.140 |
Why?
|
Piperazines | 4 | 2020 | 2554 | 0.140 |
Why?
|
Bile Duct Neoplasms | 2 | 2014 | 614 | 0.140 |
Why?
|
Receptors, Steroid | 1 | 2017 | 156 | 0.140 |
Why?
|
Up-Regulation | 3 | 2008 | 4146 | 0.140 |
Why?
|
Receptors, Androgen | 1 | 2023 | 1089 | 0.140 |
Why?
|
PTEN Phosphohydrolase | 2 | 2019 | 1120 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2019 | 354 | 0.130 |
Why?
|
SOXB1 Transcription Factors | 1 | 2018 | 286 | 0.130 |
Why?
|
Estrogens | 1 | 2023 | 1536 | 0.130 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2020 | 827 | 0.130 |
Why?
|
Aneuploidy | 1 | 2020 | 573 | 0.130 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1998 | 414 | 0.130 |
Why?
|
Androgens | 1 | 2023 | 1281 | 0.130 |
Why?
|
Cytomegalovirus | 1 | 2020 | 753 | 0.120 |
Why?
|
Multiprotein Complexes | 2 | 2012 | 1110 | 0.120 |
Why?
|
Pyrimidinones | 1 | 2017 | 386 | 0.120 |
Why?
|
Heredity | 1 | 2015 | 149 | 0.120 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2017 | 296 | 0.120 |
Why?
|
Middle Aged | 21 | 2024 | 223492 | 0.120 |
Why?
|
Mice, SCID | 1 | 2020 | 2627 | 0.120 |
Why?
|
DNA Mismatch Repair | 1 | 2018 | 431 | 0.120 |
Why?
|
DNA Repair | 1 | 2024 | 2050 | 0.120 |
Why?
|
Genotype | 9 | 2021 | 13045 | 0.120 |
Why?
|
Cadherins | 1 | 2019 | 905 | 0.120 |
Why?
|
Protein Kinase Inhibitors | 3 | 2023 | 5703 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 4 | 2014 | 4528 | 0.120 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2016 | 2892 | 0.110 |
Why?
|
Androgen Antagonists | 1 | 2023 | 1412 | 0.110 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2014 | 304 | 0.110 |
Why?
|
Cells, Cultured | 5 | 2012 | 19015 | 0.110 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2227 | 0.110 |
Why?
|
Glioma | 3 | 2014 | 3503 | 0.110 |
Why?
|
Physical Conditioning, Animal | 1 | 2017 | 363 | 0.110 |
Why?
|
Adipocytes | 1 | 2020 | 1197 | 0.110 |
Why?
|
Piperidines | 1 | 2022 | 1667 | 0.110 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2014 | 2059 | 0.110 |
Why?
|
Cell Differentiation | 6 | 2018 | 11669 | 0.110 |
Why?
|
Protein Biosynthesis | 4 | 2011 | 2094 | 0.110 |
Why?
|
Brain Neoplasms | 4 | 2019 | 9118 | 0.110 |
Why?
|
Smoking | 1 | 2010 | 9092 | 0.110 |
Why?
|
Mice, Inbred C57BL | 7 | 2021 | 22379 | 0.110 |
Why?
|
Neoadjuvant Therapy | 6 | 2023 | 2907 | 0.110 |
Why?
|
Fibroblast Growth Factor 7 | 1 | 2013 | 59 | 0.110 |
Why?
|
Adult | 18 | 2024 | 223646 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2011 | 1151 | 0.110 |
Why?
|
Sirtuins | 2 | 2021 | 322 | 0.110 |
Why?
|
Lymphocyte Activation | 2 | 2020 | 5505 | 0.110 |
Why?
|
Hepatoblastoma | 1 | 2013 | 90 | 0.110 |
Why?
|
STAT5 Transcription Factor | 1 | 2014 | 268 | 0.110 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 1351 | 0.100 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2013 | 99 | 0.100 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2015 | 249 | 0.100 |
Why?
|
Models, Biological | 5 | 2019 | 9495 | 0.100 |
Why?
|
Pyridones | 1 | 2017 | 819 | 0.100 |
Why?
|
Blotting, Western | 3 | 2016 | 5027 | 0.100 |
Why?
|
Prognosis | 6 | 2019 | 30010 | 0.100 |
Why?
|
Glutarates | 1 | 2014 | 242 | 0.100 |
Why?
|
Genomics | 2 | 2021 | 5926 | 0.100 |
Why?
|
Fatty Acids | 1 | 2020 | 1812 | 0.100 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2019 | 1536 | 0.100 |
Why?
|
Transfection | 4 | 2012 | 5755 | 0.100 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2019 | 1099 | 0.100 |
Why?
|
Genetic Counseling | 1 | 2015 | 635 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2017 | 2457 | 0.090 |
Why?
|
California | 1 | 2015 | 1438 | 0.090 |
Why?
|
Osteosarcoma | 2 | 2016 | 911 | 0.090 |
Why?
|
Genomic Instability | 1 | 2015 | 716 | 0.090 |
Why?
|
Aged | 16 | 2024 | 171504 | 0.090 |
Why?
|
Receptor, erbB-2 | 3 | 2010 | 2603 | 0.090 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2040 | 0.090 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 1991 | 168 | 0.090 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2010 | 507 | 0.090 |
Why?
|
Milk Proteins | 1 | 2010 | 161 | 0.090 |
Why?
|
Gallbladder Neoplasms | 1 | 2011 | 190 | 0.090 |
Why?
|
Carcinosarcoma | 1 | 2010 | 108 | 0.080 |
Why?
|
Hydroxamic Acids | 1 | 2012 | 483 | 0.080 |
Why?
|
Carcinoma | 1 | 2021 | 2332 | 0.080 |
Why?
|
Gene Deletion | 2 | 2016 | 2675 | 0.080 |
Why?
|
Exercise Tolerance | 1 | 2015 | 846 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2015 | 3800 | 0.080 |
Why?
|
NIH 3T3 Cells | 1 | 2011 | 669 | 0.080 |
Why?
|
Alphapapillomavirus | 1 | 2012 | 219 | 0.080 |
Why?
|
Disease Progression | 3 | 2023 | 13671 | 0.080 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3620 | 0.080 |
Why?
|
Pharmacogenetics | 1 | 2013 | 683 | 0.080 |
Why?
|
RNA, Messenger | 7 | 2016 | 12800 | 0.080 |
Why?
|
Cell Lineage | 1 | 2018 | 2575 | 0.080 |
Why?
|
Drug Synergism | 1 | 2012 | 1760 | 0.080 |
Why?
|
Hematopoietic Stem Cells | 1 | 2001 | 3409 | 0.080 |
Why?
|
Antigens, CD | 1 | 2019 | 4035 | 0.080 |
Why?
|
Telomerase | 3 | 1998 | 751 | 0.080 |
Why?
|
Cell Transformation, Viral | 1 | 2010 | 530 | 0.080 |
Why?
|
Gene Frequency | 1 | 2015 | 3623 | 0.080 |
Why?
|
Trachea | 1 | 2014 | 1095 | 0.080 |
Why?
|
Antioxidants | 2 | 2021 | 1673 | 0.070 |
Why?
|
Fibroblasts | 3 | 2010 | 4176 | 0.070 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1996 | 0.070 |
Why?
|
Genes, ras | 1 | 2010 | 663 | 0.070 |
Why?
|
Point Mutation | 1 | 2013 | 1596 | 0.070 |
Why?
|
Pedigree | 1 | 2015 | 4539 | 0.070 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1668 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2018 | 1481 | 0.070 |
Why?
|
Benzamides | 1 | 2013 | 1379 | 0.070 |
Why?
|
Monomeric GTP-Binding Proteins | 2 | 2006 | 199 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4580 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4860 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2018 | 3474 | 0.070 |
Why?
|
DNA Methylation | 4 | 2019 | 4428 | 0.070 |
Why?
|
Lung Neoplasms | 3 | 2018 | 13586 | 0.070 |
Why?
|
Ascorbic Acid | 1 | 2010 | 658 | 0.070 |
Why?
|
Gene Expression Profiling | 4 | 2015 | 9538 | 0.070 |
Why?
|
Organogenesis | 1 | 2008 | 214 | 0.070 |
Why?
|
RNA, Small Interfering | 3 | 2020 | 3428 | 0.070 |
Why?
|
Blotting, Northern | 2 | 2002 | 1550 | 0.070 |
Why?
|
Tobacco Use Disorder | 1 | 2012 | 708 | 0.070 |
Why?
|
Anoikis | 1 | 2006 | 49 | 0.070 |
Why?
|
Antigens, Surface | 1 | 2010 | 1617 | 0.070 |
Why?
|
Neoplasm Staging | 3 | 2017 | 11244 | 0.070 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2010 | 681 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4648 | 0.060 |
Why?
|
Women's Health | 1 | 2016 | 2082 | 0.060 |
Why?
|
Telemedicine | 1 | 2023 | 3109 | 0.060 |
Why?
|
Animals, Newborn | 1 | 2011 | 2678 | 0.060 |
Why?
|
Genes, bcl-2 | 1 | 2006 | 119 | 0.060 |
Why?
|
In Situ Hybridization | 3 | 2010 | 1903 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 379 | 0.060 |
Why?
|
Genital Neoplasms, Female | 1 | 2010 | 536 | 0.060 |
Why?
|
Cell Line | 4 | 2020 | 15597 | 0.060 |
Why?
|
Protein Binding | 4 | 2017 | 9343 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2784 | 0.060 |
Why?
|
Receptors, Progesterone | 1 | 2010 | 1160 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 2014 | 1183 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2001 | 10266 | 0.060 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2007 | 719 | 0.060 |
Why?
|
Cloning, Molecular | 3 | 2002 | 4168 | 0.060 |
Why?
|
Glucose | 2 | 2020 | 4352 | 0.060 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 2014 | 0.060 |
Why?
|
Glioblastoma | 1 | 2019 | 3464 | 0.060 |
Why?
|
Muscle, Skeletal | 2 | 2017 | 4978 | 0.060 |
Why?
|
Transduction, Genetic | 1 | 2006 | 899 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2016 | 2565 | 0.050 |
Why?
|
Binding Sites | 2 | 2010 | 6020 | 0.050 |
Why?
|
Enzyme Activation | 3 | 2005 | 3590 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4786 | 0.050 |
Why?
|
Cell Size | 1 | 2005 | 626 | 0.050 |
Why?
|
Rad51 Recombinase | 1 | 2024 | 191 | 0.050 |
Why?
|
Hedgehog Proteins | 1 | 2008 | 771 | 0.050 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2009 | 493 | 0.050 |
Why?
|
Neuropeptides | 2 | 2006 | 951 | 0.050 |
Why?
|
Colonic Neoplasms | 2 | 2014 | 2541 | 0.050 |
Why?
|
Sirolimus | 1 | 2010 | 1540 | 0.050 |
Why?
|
Pyrazoles | 1 | 2013 | 2028 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2019 | 9419 | 0.050 |
Why?
|
Boston | 1 | 2015 | 9374 | 0.050 |
Why?
|
Hematopoiesis | 2 | 2002 | 2059 | 0.050 |
Why?
|
RNA Splicing | 1 | 2007 | 905 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 1991 | 2819 | 0.050 |
Why?
|
Histones | 1 | 2012 | 2601 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9263 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2002 | 816 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3728 | 0.050 |
Why?
|
NF-kappa B | 1 | 2010 | 2493 | 0.050 |
Why?
|
Molecular Biology | 2 | 2012 | 573 | 0.050 |
Why?
|
Mitochondria | 1 | 2015 | 3681 | 0.050 |
Why?
|
beta-Galactosidase | 1 | 2002 | 574 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 630 | 0.050 |
Why?
|
Sterol Esterase | 1 | 2020 | 39 | 0.050 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2429 | 0.050 |
Why?
|
DNA | 3 | 2024 | 7214 | 0.050 |
Why?
|
Drug Delivery Systems | 1 | 2012 | 2232 | 0.040 |
Why?
|
Aged, 80 and over | 5 | 2019 | 59629 | 0.040 |
Why?
|
Treatment Outcome | 6 | 2020 | 65371 | 0.040 |
Why?
|
Xenopus | 1 | 2002 | 711 | 0.040 |
Why?
|
Pentose Phosphate Pathway | 1 | 2021 | 126 | 0.040 |
Why?
|
Forkhead Transcription Factors | 1 | 2008 | 1625 | 0.040 |
Why?
|
3T3-L1 Cells | 1 | 2020 | 207 | 0.040 |
Why?
|
Starvation | 1 | 2020 | 141 | 0.040 |
Why?
|
Oncogenes | 2 | 2014 | 1234 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2009 | 2592 | 0.040 |
Why?
|
Cognition | 1 | 2018 | 7073 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2020 | 3556 | 0.040 |
Why?
|
Papillomavirus Infections | 1 | 2012 | 1640 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2016 | 1703 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2020 | 6847 | 0.040 |
Why?
|
Cell Adhesion | 1 | 2006 | 3096 | 0.040 |
Why?
|
RNA | 3 | 1998 | 2720 | 0.040 |
Why?
|
Conserved Sequence | 1 | 2002 | 1162 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2012 | 4045 | 0.040 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2024 | 606 | 0.040 |
Why?
|
Dexamethasone | 1 | 2006 | 1965 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15454 | 0.040 |
Why?
|
Down-Regulation | 2 | 2004 | 2937 | 0.040 |
Why?
|
Risk Assessment | 2 | 2022 | 24315 | 0.040 |
Why?
|
Drosophila melanogaster | 1 | 2008 | 1726 | 0.040 |
Why?
|
Genetic Variation | 1 | 2014 | 6611 | 0.040 |
Why?
|
Retroviridae | 1 | 2001 | 846 | 0.040 |
Why?
|
Drosophila Proteins | 1 | 2008 | 1712 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2014 | 6526 | 0.040 |
Why?
|
Adenoviridae | 1 | 2002 | 1092 | 0.040 |
Why?
|
Glutathione | 1 | 2021 | 589 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2002 | 2748 | 0.040 |
Why?
|
Cell Cycle | 1 | 2006 | 2932 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 13090 | 0.040 |
Why?
|
RNA, Neoplasm | 1 | 2021 | 749 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 4055 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2002 | 13421 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 330 | 0.040 |
Why?
|
Cohort Studies | 3 | 2017 | 41754 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 492 | 0.040 |
Why?
|
Polymerase Chain Reaction | 3 | 2012 | 6082 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2023 | 81762 | 0.040 |
Why?
|
Aerobiosis | 1 | 2017 | 100 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2013 | 4362 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2002 | 1103 | 0.040 |
Why?
|
Matrix Metalloproteinases | 1 | 2020 | 393 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2013 | 4530 | 0.040 |
Why?
|
Risk Factors | 4 | 2020 | 74944 | 0.040 |
Why?
|
Allelic Imbalance | 1 | 2017 | 77 | 0.040 |
Why?
|
Phosphorylation | 2 | 2005 | 8317 | 0.040 |
Why?
|
Endoderm | 1 | 2018 | 165 | 0.040 |
Why?
|
Muscle Fatigue | 1 | 2017 | 96 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2014 | 2521 | 0.030 |
Why?
|
Base Sequence | 2 | 2002 | 12421 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2002 | 17622 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2017 | 165 | 0.030 |
Why?
|
E2F Transcription Factors | 1 | 2017 | 270 | 0.030 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 1998 | 115 | 0.030 |
Why?
|
Corticosterone | 1 | 2017 | 301 | 0.030 |
Why?
|
Germ Cells | 1 | 2020 | 644 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6395 | 0.030 |
Why?
|
Gene Expression | 3 | 2001 | 7598 | 0.030 |
Why?
|
Purines | 1 | 2019 | 615 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2021 | 864 | 0.030 |
Why?
|
Immunomodulation | 1 | 2020 | 549 | 0.030 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 1998 | 458 | 0.030 |
Why?
|
Aminopyridines | 1 | 2019 | 580 | 0.030 |
Why?
|
Survival Analysis | 2 | 2019 | 10101 | 0.030 |
Why?
|
Receptors, Glucocorticoid | 1 | 2017 | 309 | 0.030 |
Why?
|
Fluorouracil | 1 | 2020 | 1652 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2002 | 2633 | 0.030 |
Why?
|
Stem Cells | 1 | 2008 | 3537 | 0.030 |
Why?
|
Gene Amplification | 1 | 2019 | 1095 | 0.030 |
Why?
|
RNA, Untranslated | 1 | 1998 | 455 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2017 | 753 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 1767 | 0.030 |
Why?
|
Cytosol | 1 | 2017 | 887 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 1999 | 1245 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2001 | 2732 | 0.030 |
Why?
|
Pregnancy | 2 | 2014 | 30256 | 0.030 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2018 | 526 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2021 | 1627 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2001 | 2414 | 0.030 |
Why?
|
Hydrogels | 1 | 2019 | 744 | 0.030 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2020 | 952 | 0.030 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2014 | 354 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2020 | 1361 | 0.030 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2014 | 182 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1613 | 0.030 |
Why?
|
Male | 15 | 2019 | 364719 | 0.030 |
Why?
|
Embryonic Development | 1 | 2018 | 724 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5432 | 0.030 |
Why?
|
Leukemia | 1 | 2001 | 1519 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2018 | 3610 | 0.030 |
Why?
|
Adult Children | 1 | 2013 | 104 | 0.030 |
Why?
|
Tissue Scaffolds | 1 | 2019 | 951 | 0.030 |
Why?
|
Pilot Projects | 2 | 2022 | 8741 | 0.020 |
Why?
|
Remission Induction | 1 | 2018 | 2410 | 0.020 |
Why?
|
Nuclear Family | 1 | 2013 | 311 | 0.020 |
Why?
|
Survival Rate | 2 | 2018 | 12840 | 0.020 |
Why?
|
Mammography | 1 | 2022 | 2433 | 0.020 |
Why?
|
Monocytes | 1 | 2001 | 2605 | 0.020 |
Why?
|
Genetic Markers | 1 | 1998 | 2603 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2001 | 3402 | 0.020 |
Why?
|
Valine | 1 | 2013 | 410 | 0.020 |
Why?
|
Young Adult | 5 | 2019 | 60066 | 0.020 |
Why?
|
3T3 Cells | 2 | 2004 | 1084 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 1998 | 985 | 0.020 |
Why?
|
Receptors, Vitronectin | 1 | 2010 | 48 | 0.020 |
Why?
|
Gene Silencing | 1 | 2017 | 1505 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 1998 | 1793 | 0.020 |
Why?
|
Restriction Mapping | 1 | 1991 | 849 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 1991 | 310 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2023 | 3620 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2012 | 428 | 0.020 |
Why?
|
GTP Phosphohydrolases | 1 | 2014 | 525 | 0.020 |
Why?
|
Integrin alphaVbeta3 | 1 | 2010 | 103 | 0.020 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1512 | 0.020 |
Why?
|
Metformin | 1 | 2017 | 909 | 0.020 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 1991 | 534 | 0.020 |
Why?
|
Brain | 2 | 2019 | 27360 | 0.020 |
Why?
|
Glucose Transporter Type 1 | 1 | 2010 | 186 | 0.020 |
Why?
|
Cell Respiration | 1 | 2010 | 201 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2013 | 1497 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1752 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2017 | 2885 | 0.020 |
Why?
|
Chromosome Disorders | 1 | 1991 | 498 | 0.020 |
Why?
|
Astrocytoma | 1 | 2013 | 774 | 0.020 |
Why?
|
Oligonucleotides | 1 | 1991 | 563 | 0.020 |
Why?
|
Endometrial Neoplasms | 1 | 2018 | 1382 | 0.020 |
Why?
|
Receptor, Notch1 | 1 | 1991 | 519 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3239 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1606 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1991 | 812 | 0.020 |
Why?
|
Parapsoriasis | 1 | 1987 | 2 | 0.020 |
Why?
|
Morphogenesis | 1 | 1991 | 746 | 0.020 |
Why?
|
Pityriasis | 1 | 1987 | 10 | 0.020 |
Why?
|
Pyridines | 1 | 2019 | 2894 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2009 | 412 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2013 | 1191 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2014 | 1758 | 0.020 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2008 | 183 | 0.020 |
Why?
|
Growth Inhibitors | 1 | 2008 | 375 | 0.020 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 620 | 0.020 |
Why?
|
Catalysis | 2 | 1998 | 768 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 26379 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3948 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 2011 | 789 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2012 | 1367 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 1991 | 1394 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5367 | 0.020 |
Why?
|
beta Catenin | 1 | 2010 | 1047 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2020 | 3187 | 0.020 |
Why?
|
Testis | 2 | 1999 | 783 | 0.010 |
Why?
|
Recurrence | 1 | 2017 | 8509 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 1991 | 1778 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 2010 | 747 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1991 | 2568 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3109 | 0.010 |
Why?
|
Combined Modality Therapy | 2 | 2009 | 8542 | 0.010 |
Why?
|
Cell Movement | 1 | 2016 | 5210 | 0.010 |
Why?
|
Ligands | 1 | 2010 | 3284 | 0.010 |
Why?
|
Species Specificity | 1 | 2008 | 2415 | 0.010 |
Why?
|
Congenital Abnormalities | 1 | 2008 | 703 | 0.010 |
Why?
|
Melanoma | 1 | 2020 | 5706 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8375 | 0.010 |
Why?
|
Adenovirus E1A Proteins | 1 | 2001 | 81 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22291 | 0.010 |
Why?
|
Genome, Human | 1 | 2014 | 4446 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8890 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12543 | 0.010 |
Why?
|
CREB-Binding Protein | 1 | 2001 | 147 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18412 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2830 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2001 | 6514 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10399 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11095 | 0.010 |
Why?
|
Luciferases | 1 | 2001 | 713 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1999 | 455 | 0.010 |
Why?
|
Zinc Fingers | 1 | 2001 | 577 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15869 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2010 | 9561 | 0.010 |
Why?
|
Rats | 2 | 2006 | 23760 | 0.010 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 440 | 0.010 |
Why?
|
HL-60 Cells | 1 | 1998 | 364 | 0.010 |
Why?
|
Cell Division | 1 | 2004 | 4473 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2006 | 2167 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21538 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2001 | 1524 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2003 | 2227 | 0.010 |
Why?
|
Gene Library | 1 | 1999 | 1064 | 0.010 |
Why?
|
Doxorubicin | 1 | 2003 | 2234 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16726 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39348 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 8054 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2006 | 8128 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 1998 | 1435 | 0.010 |
Why?
|
Paclitaxel | 1 | 2003 | 1733 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4413 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2001 | 1676 | 0.010 |
Why?
|
Adolescent | 2 | 2013 | 89169 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1997 | 2179 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 42669 | 0.010 |
Why?
|
Protein Conformation | 1 | 1997 | 3956 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1997 | 4620 | 0.000 |
Why?
|
DNA Restriction Enzymes | 1 | 1987 | 548 | 0.000 |
Why?
|
Kidney | 1 | 2001 | 7064 | 0.000 |
Why?
|
Child | 1 | 2011 | 80917 | 0.000 |
Why?
|
Lymphoproliferative Disorders | 1 | 1987 | 528 | 0.000 |
Why?
|